Search for New Oral Hypoglycemic Agents. Part V [PDF]
, 1963 S. S. Tiwari, Anand Swaroop
openalex +1 more source
Sulfonylurea and neuroprotection: The bright side of the moon
Journal of Advanced Pharmaceutical Technology & Research, 2018 Sulfonylurea (SUR) agents are the second and most used oral hypoglycemic drugs after metformin and they still as an imperative tool for most favorable of glucose control.
Nawar R Hussien +4 more
doaj +1 more source
Utility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity. [PDF]
Pulm Ther, 2023 Ge D, Foer D, Cahill KN.
europepmc +1 more source
Effects of Timing of Administration and Meal Composition on the Pharmacokinetic and Pharmacodynamic Characteristics of the Short-Acting Oral Hypoglycemic Agent Nateglinide in Healthy Subjects [PDF]
, 2001 Stephen D. Luzio
openalex +2 more sources
Studies in Potential Organo-fluorine Oral Hypoglycemic Agents. Part II. Synthesis of Some 1-Aryl-3-alkyl/aryl Sulphonylureas [PDF]
, 1965 K. C. Joshi, Jharna Sen Gupta
openalex +1 more source
Monitoring of in vitro interaction studies of enalapril with hypoglycemic agents by LC-UV
, 2013 The coadministration of antihypertensive and antidiabetic drugs is common, as both of these ailments are synergistic to each other and often occur together.
S. Naveed, N. Sultana, M. S. Arayne
semanticscholar +1 more source
Diabetic Ketoacidosis (DKA) Insulin Infusion Protocol Update Using Evidence-Based Practice: A Quality Improvement Project [PDF]
, 2018 Diabetic Ketoacidosis is a life-threatening side effect to Diabetes Mellitus. Standards of treatment and recommendations are made by the American Diabetes Association.
Lacey, Susan K
core +1 more source
Search for New Oral Hypoglycemic Agents. Part VI [PDF]
, 1964 S. S. Tiwari, A. Swaroop
openalex +1 more source
Incidence of hypoglycemia among patients with type 2 diabetes who fasted during Ramadan
Advanced Medical JournalBackground and Objectives: Fasting causes a major change in the dietary habits including the frequency, the timing, and the patterns which will result in a major change in the metabolic response of the body.
Bayar Ahmed Qasim +2 more
doaj +1 more source
Journal of Pharmaceutical Policy and Practice, 2019 Background Glycated hemoglobin (HbA1c) is accepted as the most reliable marker for assessing chronic glycemia. The present study aimed to investigate glycemic control in cardiovascular outcome trials (CVOTs) performed by pharmaceutical sponsors, at the ...
Rumiko Shimazawa, Masayuki Ikeda
doaj +1 more source